Human and Murine ApoE Markedly Alters Aβ Metabolism before and after Plaque Formation in a Mouse Model of Alzheimer's Disease
- 1 April 2002
- journal article
- research article
- Published by Elsevier in Neurobiology of Disease
- Vol. 9 (3), 305-318
- https://doi.org/10.1006/nbdi.2002.0483
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- Human apolipoprotein E4 accelerates β‐amyloid deposition in APPsw transgenic mouse brainAnnals of Neurology, 2001
- Influence of lipoproteins on microglial degradation of Alzheimer's amyloid beta-proteinMicroscopy Research and Technique, 2000
- Apolipoprotein E is essential for amyloid deposition in the APP V717F transgenic mouse model of Alzheimer's diseaseProceedings of the National Academy of Sciences, 1999
- Apolipoprotein E isoform-specific reduction of extracellular amyloid in neuronal culturesMolecular Brain Research, 1999
- Lack of apolipoprotein E dramatically reduces amyloid β-peptide depositionNature Genetics, 1997
- Lipid Binding to Amyloid β‐Peptide Aggregates: Preferential Binding of Cholesterol as Compared with Phosphatidylcholine and Fatty AcidsJournal of Neurochemistry, 1997
- Acceleration of Amyloid Fibril Formation by Specific Binding of Aβ-(1–40) Peptide to Ganglioside-containing Membrane VesiclesJournal of Biological Chemistry, 1997
- Flotillin and Epidermal Surface Antigen Define a New Family of Caveolae-associated Integral Membrane ProteinsJournal of Biological Chemistry, 1997
- Co-expression of β-amyloid precursor protein (βAPP) and apolipoprotein E in cell culture: analysis of βAPP processingNeurobiology of Disease, 1995
- Fibrillogenesis in Alzheimer's disease of amyloid β peptides and apolipoprotein EBiochemical Journal, 1995